The investment bank began coverage with an Outperform rating, noting that Horizon's recent acquisition of Dharmacon is highly complementary and synergistic.
By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.
In Genome Biology this week: dynamics of sex-determining regions in brown algae, genome-engineering software tool, and more.
The bioengineering firm Oxitec is developing a moth to stop an agricultural pest, Wired reports.
The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.
The authors framed their report as a guidebook to help regulatory agencies across the globe coordinate "consistent" rules while allowing for societal differences.
IDT has licensed the CRISPR/Cpf1 RNA-guided editing system from the Broad Institute and intends to sell it to pharmaceutical and other commercial labs.
The firms will continue to develop strains of algae that demonstrate improved photosynthetic efficiency and oil production.
Researchers uncover anti-CRISPR proteins that could help genetic engineering to be safer.
In PNAS this week: deep phenotyping of xeroderma pigmentosum, role of PREX2 mutations in melanoma development, and more.
Using DNA to sketch crime victims might not be a great idea, the NYTimes says.
Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.
Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.
In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.